Aetna^® community vaccine clinics

Transcript (English):

AISHA OLIVER: mRNA instructs the cell on how to make a piece of the spike protein that's very unique to this virus. Viral vector vaccines use a modified virus, which delivers a gene that instructs our cells on how to make an antigen called the spike protein. The spike protein then instructs the cells on creating antibodies. Those antibodies then trigger an immune response, which can prevent future infections because it allows your body to recognize that foreign substance.

Transcript (Spanish):

AISHA OLIVER: El ARN mensajero es exactamente eso, es un mensajero. Y un mensajero es algo que le dé instrucciones a la célula sobre cómo fabricar un pedazo de la proteína de la espícula conocido como un [INGLÉS]. Ahora, esta proteína es exclusiva a este virus y hace que el sistema inmunológico comience a producir anticuerpos.

¿Qué quiere decir eso? Eso significa que el cuerpo se está preparando para protegerse contra futuras infecciones. Ahora, las vacunas de vectores virales utilizan un virus modificado que libera un gen que instruye a nuestras células a producir un antígeno. Este antígeno desencadena la producción de anticuerpos necesarios para una respuesta inmunológica. La ciencia sinceramente es una maravilla.

Transcript (English):

LESLIE HARVEY SPARKS: So all of those that were included in the original clinical trials, those participants are still being followed up on to see how they're doing and what their long-term effects are. And just as with any vaccination that's out there, that's something that the government is always looking at, are, what are the long-term effects of any particular vaccine or medication that comes to the market? What we have found is what we're seeing in the short term and the benefits of the vaccine are definitely more positive than what we have seen with any negative outcomes.

Transcript (Spanish):

LESLIE HARVEY SPARKS: Bueno la FDA y CDC continúan monitoreando la seguridad para garantizar que se identifiquen incluso los efectos a largo plazo, pero el riesgo de una posible infección grave por COVID-19 es más peligroso comparado con lo que se conoce actualmente sobre la seguridad de las vacunas.

Transcript (English):

DR. LESLIE HARVEY SPARKS: Even if you've had COVID-19, you've overcome it and you're well now, we're still learning how long your immunity is going to last. So you still want to get vaccinated the first opportunity that you're eligible.

If you received plasma treatment, you received antibodies, we definitely still encourage you to also be vaccinated against COVID-19. We ask that you wait 90 days. But as soon as that 90-day period is over with, we ask you to get vaccinated as soon as you're eligible.

Transcript (Spanish):
Sí, debe vacunarse sin importar si tuvo la enfermedad. Los expertos todavía no saben cuánto tiempo está protegido, o sabe cuánto tiempo para uno enfermarse nuevamente luego de que se haya recuperado. Si recibió un tratamiento para la COVID-19 con anticuerpos monoclonales, o plasma de personas convalecientes, debería esperar 90 días antes de vacunarse. Pero hable con su médico si no está seguro.